Clinical Management and Outcomes in Patients with Hyperfunctioning Distant Metastases from Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Therapy

Qiu Zhong-Ling; Shen Chen-Tian; Luo Quan-Yong

首页> 外文期刊>Thyroid: official journal of the American Thyroid Association >Clinical Management and Outcomes in Patients with Hyperfunctioning Distant Metastases from Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Therapy

【24h】

Clinical Management and Outcomes in Patients with Hyperfunctioning Distant Metastases from Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Therapy

机译：甲状腺全切除术和放射性碘治疗后分化型甲状腺癌功能亢进远处转移患者的临床管理和结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Hyperfunctioning distant metastasis (HFDM) from differentiated thyroid cancer (DTC) is a rare entity. This study aimed to assess the outcomes of DTC patients presenting with HFDM after total thyroidectomy and radioactive iodine therapy.

机译：背景：来自分化型甲状腺癌（DTC）的功能亢进的远处转移（HFDM）是一种罕见的实体。这项研究旨在评估完全甲状腺切除术和放射性碘治疗后伴有HFDM的DTC患者的结局。

著录项

来源
《Thyroid: official journal of the American Thyroid Association》 |2015年第2期|共9页
作者
Qiu Zhong-Ling; Shen Chen-Tian; Luo Quan-Yong;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Clinical Management and Outcomes in Patients with Hyperfunctioning Distant Metastases from Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Therapy [J] . Qiu Zhong-Ling, Shen Chen-Tian, Luo Quan-Yong Thyroid: official journal of the American Thyroid Association . 2015,第2期

机译：甲状腺全切除术和放射性碘治疗后分化型甲状腺癌功能亢进远处转移患者的临床管理和结果
2. Dynamic Risk Estimates of Outcome in Chinese Patients with Well-Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation [J] . Shen Feng-Chih, Hsieh Ching-Jung, Huang I-Chin, Thyroid: official journal of the American Thyroid Association . 2017,第4期

机译：甲状腺切除术后甲状腺癌良好分化甲状腺癌患者的动态风险估计和放射性碘残余烧蚀
3. Negative remnant Tc-99m-pertechnetate uptake predicts excellent response to radioactive iodine therapy in low- to intermediate-risk differentiated thyroid cancer patients who have undergone total thyroidectomy [J] . Wei Lan, Zhao Gege, Lv Ningning, Annals of nuclear medicine . 2019,第2期

机译：阴性残余TC-99M-Pertechnetate摄取预测对低至中等风险分化的放射性碘治疗的优异反应，分化过度甲状腺切除术的甲状腺癌患者
4. Clinical Engineering and Clinical Dosimetry in Patients with Differentiated Thyroid Cancer Undergoing Thyroid Remnant Ablation with Radioiodine-131 [C] . M. Medvedec, D. Dodig 12th Mediterranean conference on medical and biological engineering and computing 2010 . 2010

机译：放射性碘131消融甲状腺分化型甲状腺癌患者的临床工程和临床剂量
5. Effect of Patient Activation on Patient Health Outcomes: An Assessment of the Relationship between an Advanced Care Management Program Using Coaching for Activation and Clinical, Utilization, and Risk for Admission Outcomes [D] . Ginnetti, Richard M. 2020

机译：患者激活对患者健康结果的影响：使用辅导激活和临床，利用以及入学成果风险的高级护理管理计划关系的评估
6. Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging System [O] . R. Michael Tuttle, Hernan Tala, Jatin Shah, -1

机译：评估全甲状腺切除术和放射性碘残留消融后分化型甲状腺癌的复发风险：使用对治疗变量的反应来修改美国新甲状腺协会分期系统预测的初始风险估计
7. Radioactive iodine therapy at the outpatient department for high-risk patients with differentiated thyroid cancer after total thyroidectomy [O] . Hiroshi Iwai, Keita Utsunomiya, Masaya Konishi, 2014

机译：在总甲状腺切除术后，在高危甲状腺癌的高风险患者的外部碘治疗的放射性碘治疗

Clinical Management and Outcomes in Patients with Hyperfunctioning Distant Metastases from Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Therapy

摘要

著录项

相似文献

相关主题

期刊订阅